Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3

Figure 4

DR3 activation triggers NFκB activation through PI3K. HT29 cells were pre-treated for 2 hours with PI3K inhibitor LY294002 (20 μM) or DMSO as vehicle (0.1%) and treated or not with rhE-selectin/Fc (5 ng/ml for 15 min). Nuclear proteins were extracted and processed for western blotting using specific antibodies for total p65 NFκB or for TATA binding protein (TBP) used as nuclear protein control.

Back to article page